TrialHead & neck2020

Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatin.

Paul L Swiecicki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.